DNAPrint Genomics, Inc. (DNAG)

Market Cap	1.30K
Revenue (ttm)	1.93M -15.2%
Net Income	-4.55M
EPS	-0.01
Shares Out	1.29B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	331,500
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.000001 - 0.0001
Beta	81.14
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DNAPrint Genomics

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an in...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 25
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNAG

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 25, 2026

Data Sources Report a data error